| SNA |
Report |
Q2 2026 net sales |
BEAT |
pred ~$1.25B vs. cons $1.22B |
MEDIUM |
| SNA |
Report |
Q2 2026 diluted EPS |
MISS |
pred ~$4.86 vs. cons $4.92 |
MEDIUM |
| SNA |
Report |
Q2 2026 operating margin before Financial Services |
MISS |
pred ~21.5% vs. cons 21.8% |
MEDIUM |
| SNA |
Guide |
Capital expenditures |
UNCHANGED |
guide ~$100M vs. cons $100M (FY2026) |
HIGH |
| SNA |
Guide |
Effective income tax rate |
UNCHANGED |
guide ~22.5% vs. cons 22.5% (FY2026) |
HIGH |
| SNA |
Guide |
Corporate expense per quarter |
UNCHANGED |
guide ~$28M vs. cons $28M (H2 2026 quarterly) |
HIGH |
| SNA |
Return |
Day-1 residual (stock − beta × S&P 500) |
-3.0% |
— |
MEDIUM |
| SNA |
Return |
5-day cumulative residual |
-4.2% (FOLLOW-THROUGH) |
5-day residual ~-4.2% vs. day-1 residual ~-3.0%; acquisition and cost-related margin dilution outweighs the acquisition-aided revenue beat, driving modest out-period EPS estimate cuts after the report. |
MEDIUM |